Cliff Asness's MXCT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.22 M shares of MaxCyte, Inc. (MXCT) worth $857,881, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MXCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 1.13 M shares. Largest reduction occurred in Q4 2025, reducing 297,019 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's MaxCyte (MXCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly MaxCyte (MXCT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.13 M | Add 1199.49% | 1.22 M | $0.70 |
| Q4 2025 | -297,019 | Reduce 75.97% | 93,974 | $1.55 |
| Q3 2025 | +143,300 | Add 57.85% | 390,993 | $1.58 |
| Q2 2025 | +152,192 | Add 159.36% | 247,693 | $2.18 |
| Q1 2025 | +66,323 | Add 227.30% | 95,501 | $2.73 |
| Q4 2024 | +16,613 | Add 132.22% | 29,178 | $4.16 |
| Q3 2024 | -924 | Reduce 6.85% | 12,565 | $3.89 |
| Q2 2024 | -1,906 | Reduce 12.38% | 13,489 | $3.92 |
| Q1 2024 | -13,919 | Reduce 47.48% | 15,395 | $4.19 |
| Q4 2023 | +13,450 | Add 84.78% | 29,314 | $4.70 |
| Q3 2023 | +15,864 | New Buy | 15,864 | $3.12 |
Cliff Asness's MaxCyte Investment FAQs
Cliff Asness first purchased MaxCyte, Inc. (MXCT) in Q3 2023, acquiring 15,864 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held MaxCyte, Inc. (MXCT) for 11 quarters since Q3 2023.
Cliff Asness's largest addition to MaxCyte, Inc. (MXCT) was in Q1 2026, adding 1,221,182 shares worth $857,881.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,221,182 shares of MaxCyte, Inc. (MXCT), valued at approximately $857,881.
As of the Q1 2026 filing, MaxCyte, Inc. (MXCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in MaxCyte, Inc. (MXCT) was 1,221,182 shares, as reported at the end of Q1 2026.